

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.28880985 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.45927552 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.32884927 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.08572338 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.08572338 |
| 6 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.87113770 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83366894 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83366894 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.80732213 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.74900255 |
| 11 | activation of MAPKKK activity (GO:0000185) | 4.58008190 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.54896680 |
| 13 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.41032330 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.40872351 |
| 15 | negative regulation of granulocyte differentiation (GO:0030853) | 4.36745537 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 4.29642350 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.26499238 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.26499238 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.26499238 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.26499238 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.26499238 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.26499238 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26470503 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.25496080 |
| 25 | cellular extravasation (GO:0045123) | 4.09812696 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.09259670 |
| 27 | regulation of B cell differentiation (GO:0045577) | 4.07172251 |
| 28 | detection of other organism (GO:0098543) | 3.94539220 |
| 29 | detection of bacterium (GO:0016045) | 3.94340976 |
| 30 | positive thymic T cell selection (GO:0045059) | 3.94091034 |
| 31 | positive regulation of chemokine secretion (GO:0090197) | 3.86788160 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.78546028 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69683880 |
| 34 | microglial cell activation (GO:0001774) | 3.66478505 |
| 35 | germinal center formation (GO:0002467) | 3.64856937 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.64762121 |
| 37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.63827509 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.63413676 |
| 39 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.46892375 |
| 40 | lymphocyte chemotaxis (GO:0048247) | 3.45801978 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.45417276 |
| 42 | regulation of lymphocyte migration (GO:2000401) | 3.45131189 |
| 43 | B cell mediated immunity (GO:0019724) | 3.44045289 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.43476114 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.42503750 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.40751418 |
| 47 | tolerance induction (GO:0002507) | 3.39216384 |
| 48 | cellular response to zinc ion (GO:0071294) | 3.38826050 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.35714669 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.34724223 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.32899859 |
| 52 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31917058 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.31609965 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.29693955 |
| 55 | granulocyte activation (GO:0036230) | 3.29250813 |
| 56 | detection of external biotic stimulus (GO:0098581) | 3.28139318 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 3.26872978 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26376828 |
| 59 | natural killer cell differentiation (GO:0001779) | 3.25901283 |
| 60 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.22204531 |
| 61 | negative T cell selection (GO:0043383) | 3.22111467 |
| 62 | leukocyte aggregation (GO:0070486) | 3.20876761 |
| 63 | neutrophil activation (GO:0042119) | 3.20830284 |
| 64 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.20541151 |
| 65 | mannose metabolic process (GO:0006013) | 3.19119583 |
| 66 | negative regulation of bone resorption (GO:0045779) | 3.17931048 |
| 67 | DNA deamination (GO:0045006) | 3.17109523 |
| 68 | negative thymic T cell selection (GO:0045060) | 3.13861139 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13234837 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.12904295 |
| 71 | respiratory burst (GO:0045730) | 3.12869705 |
| 72 | mature B cell differentiation (GO:0002335) | 3.12794421 |
| 73 | T-helper 1 type immune response (GO:0042088) | 3.12767768 |
| 74 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12125798 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.11877514 |
| 76 | interferon-gamma production (GO:0032609) | 3.11753628 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11728176 |
| 78 | positive T cell selection (GO:0043368) | 3.11215785 |
| 79 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.10934256 |
| 80 | positive regulation of defense response to virus by host (GO:0002230) | 3.09891506 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09239284 |
| 82 | response to type I interferon (GO:0034340) | 3.08612834 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07455711 |
| 84 | mast cell activation (GO:0045576) | 3.07184747 |
| 85 | negative regulation of interleukin-6 production (GO:0032715) | 3.06043892 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 3.05888871 |
| 87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04880953 |
| 88 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.04377651 |
| 89 | thymic T cell selection (GO:0045061) | 3.04165263 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04097935 |
| 91 | cellular response to type I interferon (GO:0071357) | 3.03642599 |
| 92 | type I interferon signaling pathway (GO:0060337) | 3.03642599 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03332079 |
| 94 | detection of biotic stimulus (GO:0009595) | 3.02910631 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01927486 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01627677 |
| 97 | positive regulation of B cell mediated immunity (GO:0002714) | 3.01429628 |
| 98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.01429628 |
| 99 | actin nucleation (GO:0045010) | 2.99439033 |
| 100 | T cell migration (GO:0072678) | 2.99108382 |
| 101 | response to peptidoglycan (GO:0032494) | 2.97160333 |
| 102 | lymphocyte migration (GO:0072676) | 2.96104303 |
| 103 | regulation of granulocyte differentiation (GO:0030852) | 2.95886434 |
| 104 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95050270 |
| 105 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94187823 |
| 106 | response to interleukin-15 (GO:0070672) | 2.93661140 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.93512314 |
| 108 | regulation of T cell tolerance induction (GO:0002664) | 2.90034193 |
| 109 | regulation of mast cell activation (GO:0033003) | 2.89855350 |
| 110 | macrophage activation (GO:0042116) | 2.87662125 |
| 111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.86108941 |
| 112 | regulation of chemokine secretion (GO:0090196) | 2.84823229 |
| 113 | T cell selection (GO:0045058) | 2.84551193 |
| 114 | positive regulation of Rap GTPase activity (GO:0032854) | 2.82675051 |
| 115 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.81697321 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80858011 |
| 117 | neutrophil activation involved in immune response (GO:0002283) | 2.80507268 |
| 118 | myeloid dendritic cell differentiation (GO:0043011) | 2.80197735 |
| 119 | T cell costimulation (GO:0031295) | 2.79178344 |
| 120 | T cell receptor signaling pathway (GO:0050852) | 2.78534427 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.78075039 |
| 122 | lymph node development (GO:0048535) | 2.77042441 |
| 123 | defense response to protozoan (GO:0042832) | 2.76471278 |
| 124 | regulation of monocyte differentiation (GO:0045655) | 2.75191174 |
| 125 | leukocyte cell-cell adhesion (GO:0007159) | 2.74960588 |
| 126 | lymphocyte costimulation (GO:0031294) | 2.74236407 |
| 127 | regulation of erythrocyte differentiation (GO:0045646) | 2.70853747 |
| 128 | natural killer cell activation (GO:0030101) | 2.70845513 |
| 129 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70226593 |
| 130 | pinocytosis (GO:0006907) | 2.69329611 |
| 131 | B cell proliferation (GO:0042100) | 2.68347605 |
| 132 | cytidine deamination (GO:0009972) | 2.66380340 |
| 133 | cytidine metabolic process (GO:0046087) | 2.66380340 |
| 134 | cytidine catabolic process (GO:0006216) | 2.66380340 |
| 135 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65439585 |
| 136 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65439585 |
| 137 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.65365042 |
| 138 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.65124604 |
| 139 | lymphocyte homeostasis (GO:0002260) | 2.64128814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.57944158 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73058944 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.18490500 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77855469 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60823270 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32219226 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.29428348 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.21203433 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15522230 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08871985 |
| 11 | * MYC_22102868_ChIP-Seq_BL_Human | 2.94372862 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91905478 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.75189148 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.70956096 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64158796 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56376764 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.55799866 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47647902 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41215520 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40094258 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37141947 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.36849441 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34211419 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.24917333 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22166560 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20608222 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 2.19537314 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19434423 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15062997 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13864768 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.13635865 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.13488123 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08588981 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05171753 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 2.03052735 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02374828 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79194112 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78571884 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.73989775 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73640539 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69682037 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67833315 |
| 43 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64544950 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63867496 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63409636 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62399168 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60463626 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58325290 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57712461 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56594818 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54500993 |
| 52 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52788291 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52595664 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.48055566 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47286489 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45129064 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44645447 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42724161 |
| 59 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37752192 |
| 60 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37745412 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36393083 |
| 62 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34748121 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33208683 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33076093 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32798708 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32362023 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28861003 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28771719 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27554262 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27400968 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27115480 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26992149 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24049250 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16238878 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14866536 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10309133 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06149511 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04956423 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03947829 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02457516 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01829284 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01255366 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01037083 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00436293 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99510495 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98301854 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97058072 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96414574 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96346428 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95424545 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94242692 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92329134 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92148802 |
| 94 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91654034 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88378655 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88326028 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86837741 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85630790 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84596708 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84233589 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84217667 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83328442 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83153039 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82615546 |
| 105 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.82114808 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81513743 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81381280 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 0.81253166 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80456924 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80043082 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.79547300 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76673522 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74151747 |
| 114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73940017 |
| 115 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.73200816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.99560685 |
| 2 | MP0005671_abnormal_response_to | 3.53858964 |
| 3 | MP0000685_abnormal_immune_system | 3.13434933 |
| 4 | MP0006082_CNS_inflammation | 3.07718529 |
| 5 | MP0001800_abnormal_humoral_immune | 3.05912072 |
| 6 | MP0001790_abnormal_immune_system | 2.95974748 |
| 7 | MP0005387_immune_system_phenotype | 2.95974748 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.74732607 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.71682492 |
| 10 | MP0003436_decreased_susceptibility_to | 2.69641478 |
| 11 | MP0009785_altered_susceptibility_to | 2.59689284 |
| 12 | MP0002723_abnormal_immune_serum | 2.58804778 |
| 13 | MP0005025_abnormal_response_to | 2.57505046 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.56795753 |
| 15 | MP0003303_peritoneal_inflammation | 2.52047086 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.51003332 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.50894915 |
| 18 | MP0001819_abnormal_immune_cell | 2.49384525 |
| 19 | MP0002419_abnormal_innate_immunity | 2.48313225 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.41770314 |
| 21 | MP0003724_increased_susceptibility_to | 2.38984861 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.36710751 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.33846967 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.24426951 |
| 25 | MP0002398_abnormal_bone_marrow | 2.23925869 |
| 26 | MP0004510_myositis | 2.14061852 |
| 27 | MP0000716_abnormal_immune_system | 2.12220446 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.10079219 |
| 29 | MP0002405_respiratory_system_inflammati | 2.05067621 |
| 30 | MP0005623_abnormal_meninges_morphology | 2.04860397 |
| 31 | MP0000689_abnormal_spleen_morphology | 2.01782458 |
| 32 | MP0002722_abnormal_immune_system | 1.93633820 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.85697305 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.83743521 |
| 35 | MP0004947_skin_inflammation | 1.79630889 |
| 36 | MP0002429_abnormal_blood_cell | 1.78275807 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.75969064 |
| 38 | MP0001853_heart_inflammation | 1.74003861 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.72370307 |
| 40 | MP0002006_tumorigenesis | 1.64516255 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.63594330 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.62936717 |
| 43 | MP0001873_stomach_inflammation | 1.57894163 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.54252914 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.51712040 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.50629817 |
| 47 | MP0008469_abnormal_protein_level | 1.47305444 |
| 48 | MP0002933_joint_inflammation | 1.46396518 |
| 49 | MP0009840_abnormal_foam_cell | 1.44496497 |
| 50 | MP0009278_abnormal_bone_marrow | 1.42500938 |
| 51 | MP0000343_altered_response_to | 1.41295414 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.35877203 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.35877203 |
| 54 | MP0001851_eye_inflammation | 1.33670145 |
| 55 | MP0003828_pulmonary_edema | 1.31725817 |
| 56 | MP0005310_abnormal_salivary_gland | 1.28640423 |
| 57 | MP0003075_altered_response_to | 1.23661070 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.22224049 |
| 59 | MP0003866_abnormal_defecation | 1.21387573 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.17413933 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.11275496 |
| 62 | MP0000249_abnormal_blood_vessel | 1.11061851 |
| 63 | MP0008260_abnormal_autophagy | 1.10742242 |
| 64 | MP0000604_amyloidosis | 1.06792086 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.02753149 |
| 66 | MP0003045_fibrosis | 1.01169095 |
| 67 | MP0005166_decreased_susceptibility_to | 0.99784733 |
| 68 | MP0000490_abnormal_crypts_of | 0.99699811 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.99430680 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 0.98535847 |
| 71 | MP0003448_altered_tumor_morphology | 0.96877333 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 0.96582233 |
| 73 | MP0000750_abnormal_muscle_regeneration | 0.95590814 |
| 74 | MP0005670_abnormal_white_adipose | 0.94767542 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.93940157 |
| 76 | MP0005023_abnormal_wound_healing | 0.93516582 |
| 77 | MP0009764_decreased_sensitivity_to | 0.88847098 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.88424350 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.87953114 |
| 80 | MP0000858_altered_metastatic_potential | 0.86404363 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.85327160 |
| 82 | MP0002254_reproductive_system_inflammat | 0.84762174 |
| 83 | MP0009763_increased_sensitivity_to | 0.84740850 |
| 84 | MP0001663_abnormal_digestive_system | 0.83880729 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83733229 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 0.83440977 |
| 87 | MP0010307_abnormal_tumor_latency | 0.81154055 |
| 88 | MP0005451_abnormal_body_composition | 0.78857801 |
| 89 | MP0000609_abnormal_liver_physiology | 0.78218597 |
| 90 | MP0005164_abnormal_response_to | 0.77898795 |
| 91 | MP0004381_abnormal_hair_follicle | 0.75018270 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.74881787 |
| 93 | MP0001915_intracranial_hemorrhage | 0.71641551 |
| 94 | MP0002132_abnormal_respiratory_system | 0.69926147 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.69486887 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.69164160 |
| 97 | MP0008873_increased_physiological_sensi | 0.69125486 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.67763240 |
| 99 | MP0002928_abnormal_bile_duct | 0.67025306 |
| 100 | MP0003795_abnormal_bone_structure | 0.66867262 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.65754022 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.65450512 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.64242236 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.63970698 |
| 105 | MP0003252_abnormal_bile_duct | 0.63155511 |
| 106 | MP0003279_aneurysm | 0.63081364 |
| 107 | MP0000920_abnormal_myelination | 0.62877657 |
| 108 | MP0008874_decreased_physiological_sensi | 0.62782665 |
| 109 | MP0005390_skeleton_phenotype | 0.62189602 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.61512164 |
| 111 | MP0008004_abnormal_stomach_pH | 0.58411960 |
| 112 | MP0000598_abnormal_liver_morphology | 0.58087733 |
| 113 | MP0005165_increased_susceptibility_to | 0.57465707 |
| 114 | MP0004883_abnormal_blood_vessel | 0.57426155 |
| 115 | MP0003690_abnormal_glial_cell | 0.56579956 |
| 116 | MP0006054_spinal_hemorrhage | 0.55379386 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.55262662 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.54181471 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.53268756 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.51904572 |
| 121 | MP0003786_premature_aging | 0.48375595 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.45324827 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.43477263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.41776498 |
| 2 | Retinal atrophy (HP:0001105) | 5.26060519 |
| 3 | Glomerulonephritis (HP:0000099) | 4.98433612 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.87236766 |
| 5 | Increased IgM level (HP:0003496) | 4.66353753 |
| 6 | Fatigue (HP:0012378) | 4.63127232 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.52088752 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.30176482 |
| 9 | Recurrent viral infections (HP:0004429) | 4.17406974 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.05654038 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96009553 |
| 12 | IgM deficiency (HP:0002850) | 3.85846697 |
| 13 | Optic neuritis (HP:0100653) | 3.63314401 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.63314401 |
| 15 | Myositis (HP:0100614) | 3.61293334 |
| 16 | Encephalitis (HP:0002383) | 3.58915316 |
| 17 | Complement deficiency (HP:0004431) | 3.58671862 |
| 18 | Colitis (HP:0002583) | 3.54876132 |
| 19 | Thyroiditis (HP:0100646) | 3.51998041 |
| 20 | Cellulitis (HP:0100658) | 3.50457148 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.48619457 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.43685506 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.42186072 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.39921462 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.38012084 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36036680 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.35925094 |
| 28 | Cerebellar dysplasia (HP:0007033) | 3.33998941 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.33493430 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.30559408 |
| 31 | Hematochezia (HP:0002573) | 3.29396441 |
| 32 | T lymphocytopenia (HP:0005403) | 3.28707843 |
| 33 | Recurrent skin infections (HP:0001581) | 3.27123672 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26600469 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26600469 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.26274868 |
| 37 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.22503892 |
| 38 | Nasal polyposis (HP:0100582) | 3.22222271 |
| 39 | Combined immunodeficiency (HP:0005387) | 3.19723213 |
| 40 | Chronic otitis media (HP:0000389) | 3.18365933 |
| 41 | Meningitis (HP:0001287) | 3.15415866 |
| 42 | Abnormality of complement system (HP:0005339) | 3.12492684 |
| 43 | Chronic diarrhea (HP:0002028) | 3.11585301 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11451988 |
| 45 | Eosinophilia (HP:0001880) | 3.09554123 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 3.07286413 |
| 47 | Abnormality of T cells (HP:0002843) | 3.03494116 |
| 48 | Leukocytosis (HP:0001974) | 3.03010385 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99713351 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99713351 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99713351 |
| 52 | Pustule (HP:0200039) | 2.97961881 |
| 53 | Vasculitis (HP:0002633) | 2.92911926 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.92202166 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.88505607 |
| 56 | Hypoplasia of the pons (HP:0012110) | 2.87420491 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.86335481 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.85991503 |
| 59 | Urticaria (HP:0001025) | 2.82384474 |
| 60 | Difficulty climbing stairs (HP:0003551) | 2.82160875 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.81221272 |
| 62 | Lymphopenia (HP:0001888) | 2.80317918 |
| 63 | Type II lissencephaly (HP:0007260) | 2.78018671 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.76949801 |
| 65 | Orchitis (HP:0100796) | 2.76667122 |
| 66 | Nephritis (HP:0000123) | 2.74937379 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.72582229 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.70420046 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.67702725 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.66204803 |
| 71 | Dysostosis multiplex (HP:0000943) | 2.64719401 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.64130105 |
| 73 | Granulocytopenia (HP:0001913) | 2.64010384 |
| 74 | Abnormal platelet function (HP:0011869) | 2.61322418 |
| 75 | Impaired platelet aggregation (HP:0003540) | 2.61322418 |
| 76 | Petechiae (HP:0000967) | 2.60616898 |
| 77 | Abnormality of the pons (HP:0007361) | 2.59019766 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.57214544 |
| 79 | Retinal dysplasia (HP:0007973) | 2.54662387 |
| 80 | Abnormality of B cell number (HP:0010975) | 2.54575217 |
| 81 | B lymphocytopenia (HP:0010976) | 2.54575217 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.53764428 |
| 83 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.50955743 |
| 84 | Epistaxis (HP:0000421) | 2.50136131 |
| 85 | Papilloma (HP:0012740) | 2.47720377 |
| 86 | Verrucae (HP:0200043) | 2.47720377 |
| 87 | Increased serum ferritin (HP:0003281) | 2.46060438 |
| 88 | Obstructive lung disease (HP:0006536) | 2.43148168 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43148168 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.42120073 |
| 91 | Gingivitis (HP:0000230) | 2.41708446 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.34480559 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.33882686 |
| 94 | Abnormality of the fingertips (HP:0001211) | 2.32392059 |
| 95 | IgG deficiency (HP:0004315) | 2.32346860 |
| 96 | Thrombocytosis (HP:0001894) | 2.31312967 |
| 97 | Pulmonary embolism (HP:0002204) | 2.28046216 |
| 98 | Urethral obstruction (HP:0000796) | 2.26007303 |
| 99 | Emphysema (HP:0002097) | 2.24544308 |
| 100 | Osteomyelitis (HP:0002754) | 2.24421420 |
| 101 | Slow saccadic eye movements (HP:0000514) | 2.24332244 |
| 102 | Buphthalmos (HP:0000557) | 2.24062024 |
| 103 | IgA deficiency (HP:0002720) | 2.22237320 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.21149016 |
| 105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20693271 |
| 106 | Thoracic kyphosis (HP:0002942) | 2.17975125 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16444494 |
| 108 | Joint swelling (HP:0001386) | 2.14841766 |
| 109 | Increased IgE level (HP:0003212) | 2.14491327 |
| 110 | Disinhibition (HP:0000734) | 2.13833452 |
| 111 | Loss of speech (HP:0002371) | 2.12695780 |
| 112 | Arterial thrombosis (HP:0004420) | 2.11979732 |
| 113 | Hemoptysis (HP:0002105) | 2.11788167 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.11691922 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11634426 |
| 116 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11634426 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11634426 |
| 118 | Pulmonary infiltrates (HP:0002113) | 2.10928556 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 2.10732188 |
| 120 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10398346 |
| 121 | Keratitis (HP:0000491) | 2.09722812 |
| 122 | Gingival bleeding (HP:0000225) | 2.08924596 |
| 123 | Restrictive lung disease (HP:0002091) | 2.07653415 |
| 124 | Anorexia (HP:0002039) | 2.05697880 |
| 125 | Periodontitis (HP:0000704) | 2.05307669 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 2.05075910 |
| 127 | Cheilitis (HP:0100825) | 2.04844744 |
| 128 | Stomatitis (HP:0010280) | 2.04825355 |
| 129 | Recurrent pneumonia (HP:0006532) | 2.03974389 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02622587 |
| 131 | Mucopolysacchariduria (HP:0008155) | 2.02622587 |
| 132 | Arterial tortuosity (HP:0005116) | 2.01861884 |
| 133 | Chest pain (HP:0100749) | 2.01154059 |
| 134 | Sepsis (HP:0100806) | 1.98064911 |
| 135 | Purpura (HP:0000979) | 1.94211428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.87442019 |
| 2 | TGFBR2 | 4.58529866 |
| 3 | ERN1 | 3.43495447 |
| 4 | CSF1R | 3.02875284 |
| 5 | BLK | 2.69439271 |
| 6 | TXK | 2.66701081 |
| 7 | TYK2 | 2.64779759 |
| 8 | ZAP70 | 2.60561073 |
| 9 | STK10 | 2.27284529 |
| 10 | KIT | 2.15138717 |
| 11 | TBK1 | 2.10362903 |
| 12 | MAP3K10 | 1.89277368 |
| 13 | GRK6 | 1.87382399 |
| 14 | RIPK4 | 1.83138786 |
| 15 | SYK | 1.75835355 |
| 16 | IRAK4 | 1.75833887 |
| 17 | JAK1 | 1.72696642 |
| 18 | BTK | 1.72394156 |
| 19 | TNK2 | 1.65063213 |
| 20 | HCK | 1.64851947 |
| 21 | KDR | 1.59052242 |
| 22 | GRK7 | 1.57550959 |
| 23 | CSK | 1.55501322 |
| 24 | EEF2K | 1.54975849 |
| 25 | ITK | 1.54851797 |
| 26 | IKBKE | 1.52564945 |
| 27 | CDK12 | 1.49654158 |
| 28 | TAOK1 | 1.47985024 |
| 29 | CLK1 | 1.47672305 |
| 30 | PKN2 | 1.47221024 |
| 31 | PRPF4B | 1.43492800 |
| 32 | FGR | 1.40368380 |
| 33 | MAP3K14 | 1.38111974 |
| 34 | LCK | 1.38111158 |
| 35 | CAMK1D | 1.36672555 |
| 36 | JAK3 | 1.36666233 |
| 37 | TAOK2 | 1.33474219 |
| 38 | MAP2K3 | 1.31711192 |
| 39 | TLK1 | 1.31493938 |
| 40 | TEC | 1.30434724 |
| 41 | IRAK3 | 1.28447214 |
| 42 | IKBKB | 1.26943641 |
| 43 | FES | 1.19125552 |
| 44 | LYN | 1.18814944 |
| 45 | TRIB3 | 1.18782875 |
| 46 | SIK2 | 1.18561547 |
| 47 | BMPR2 | 1.11951558 |
| 48 | MATK | 1.11511672 |
| 49 | PTK2B | 1.10960808 |
| 50 | MAPK12 | 1.09716941 |
| 51 | EPHB1 | 1.08648601 |
| 52 | MAPK7 | 1.05725082 |
| 53 | STK11 | 1.05628578 |
| 54 | CAMKK2 | 1.04286022 |
| 55 | PAK4 | 0.97734542 |
| 56 | LRRK2 | 0.96748621 |
| 57 | TIE1 | 0.96677634 |
| 58 | FLT3 | 0.96130905 |
| 59 | FGFR4 | 0.91503887 |
| 60 | MAP3K13 | 0.90857923 |
| 61 | FGFR3 | 0.90055365 |
| 62 | CDK19 | 0.89144861 |
| 63 | CAMK1G | 0.88963448 |
| 64 | MAPK15 | 0.87653641 |
| 65 | JAK2 | 0.83295804 |
| 66 | ADRBK2 | 0.79082675 |
| 67 | MAP3K1 | 0.76765626 |
| 68 | TGFBR1 | 0.76642604 |
| 69 | MAP3K7 | 0.75290512 |
| 70 | PTK6 | 0.74395795 |
| 71 | MARK3 | 0.72243275 |
| 72 | RPS6KA4 | 0.71739093 |
| 73 | MAPKAPK3 | 0.69006204 |
| 74 | CAMK4 | 0.67291601 |
| 75 | EPHA3 | 0.66913813 |
| 76 | TAOK3 | 0.66270489 |
| 77 | PIM1 | 0.61892998 |
| 78 | CHUK | 0.60929143 |
| 79 | PRKCH | 0.59517301 |
| 80 | PRKD2 | 0.58920163 |
| 81 | SIK3 | 0.58597044 |
| 82 | NEK9 | 0.56864502 |
| 83 | CDC42BPA | 0.56823514 |
| 84 | GRK5 | 0.54144507 |
| 85 | MAP3K11 | 0.53923499 |
| 86 | GRK1 | 0.53898485 |
| 87 | TESK1 | 0.52683502 |
| 88 | NLK | 0.52334119 |
| 89 | CDK4 | 0.50929045 |
| 90 | MAPKAPK2 | 0.50795119 |
| 91 | PDK1 | 0.50585177 |
| 92 | STK4 | 0.49919936 |
| 93 | IRAK1 | 0.49278416 |
| 94 | PDPK1 | 0.49067419 |
| 95 | IGF1R | 0.48843758 |
| 96 | CAMKK1 | 0.45531760 |
| 97 | MAPK4 | 0.45452387 |
| 98 | PRKCQ | 0.44708599 |
| 99 | MAP2K6 | 0.41466665 |
| 100 | NME2 | 0.41189898 |
| 101 | MAP3K5 | 0.40383706 |
| 102 | PIK3CG | 0.39893877 |
| 103 | SIK1 | 0.39784017 |
| 104 | EGFR | 0.39749275 |
| 105 | MST1R | 0.39567375 |
| 106 | TTN | 0.38515457 |
| 107 | RPS6KA6 | 0.37333167 |
| 108 | YES1 | 0.36835283 |
| 109 | HIPK2 | 0.36704975 |
| 110 | SMG1 | 0.35080867 |
| 111 | MAP3K3 | 0.34742319 |
| 112 | INSR | 0.33957397 |
| 113 | MAPK11 | 0.33933213 |
| 114 | RIPK1 | 0.33922030 |
| 115 | TESK2 | 0.33768891 |
| 116 | PDK2 | 0.33144119 |
| 117 | RPS6KC1 | 0.31942994 |
| 118 | RPS6KL1 | 0.31942994 |
| 119 | FYN | 0.31231110 |
| 120 | PRKG2 | 0.30997968 |
| 121 | PIK3CA | 0.30698439 |
| 122 | PIM2 | 0.30257759 |
| 123 | MOS | 0.30250942 |
| 124 | BCKDK | 0.30204575 |
| 125 | PRKCD | 0.30111000 |
| 126 | CAMK1 | 0.29951780 |
| 127 | ABL1 | 0.29934519 |
| 128 | MAP2K2 | 0.28515318 |
| 129 | MARK2 | 0.22973042 |
| 130 | RET | 0.21463649 |
| 131 | PRKD1 | 0.21438776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.91563088 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.88086682 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.13214004 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.92342631 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84054342 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71094555 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57858298 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.45140187 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.40538270 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30701805 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22138098 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19279424 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.13276087 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09756512 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07327350 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.06854519 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.98201390 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.97242036 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.95717311 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81687351 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79733303 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62601825 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56023447 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48852838 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47982119 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47756328 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.46991184 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46809519 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46471523 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.45494408 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.45434019 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.41220206 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40772933 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.34781105 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31748879 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.31413341 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31203096 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30032897 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26745714 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26293395 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25850689 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22268114 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.14598978 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.08676523 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.06019873 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05376407 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04663238 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.04229144 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97368524 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97327340 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.97226029 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.97073512 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95795412 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91492155 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88304819 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80791054 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.74405522 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73991523 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72936866 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71549270 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69075685 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69047276 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68676155 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66988290 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.64771258 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.59193856 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58917712 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58623725 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57534020 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56721311 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.54219810 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54080364 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.49116145 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48102587 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47887374 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.47584918 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47276151 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46902493 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46776740 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.45795353 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.43390015 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.42949434 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.41899528 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41502275 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41297348 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.38665961 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.38381314 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37084710 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36688884 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33691321 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33409043 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32571027 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32320059 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30551803 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30430476 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28940441 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27956596 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27942892 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.27656755 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26978150 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26953649 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26453709 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26311598 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24933738 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24840074 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23693122 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22689003 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21856875 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21717912 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17355297 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09806811 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09760729 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08879616 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.08738119 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07119307 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.05839685 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.03618302 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.01781781 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01732875 |

